Collaborating Care for Psoriasis & Psoriatic Arthritis Outcomes
Summary of the Article: Bridging the Gap in Psoriatic Disease Care
This article highlights the critical need for improved collaboration between dermatologists and rheumatologists in the care of patients wiht psoriasis and psoriatic arthritis (PsA). Here’s a breakdown of the key takeaways:
The Problem: Siloed Care & Delayed Diagnosis
Delayed PsA Diagnosis: Patients often experience important delays in PsA diagnosis due to fragmented healthcare systems. Referrals are missed,dermatologists may not adequately screen for joint pain,and rheumatology waitlists are long.
Patient Burden: Patients are often left to navigate the complexities of their disease and coordinate care between specialists themselves, which is a significant burden.
Siloed Practices: Dermatology and rheumatology practices operate largely independently, hindering dialog and coordinated care.
The Solution: integrated & Proactive Care
Early Detection is Key: Skin disease often precedes joint involvement, making early detection and intervention crucial.
Dermatologist Role: Dermatologists can play a vital role in identifying patients at risk for PsA through pointed history-taking and validated screening tools. Communication & co-Management: Successful care requires open communication and shared understanding of therapeutic goals between dermatologists and rheumatologists.
Potential Systemic Changes: Integrated clinics, shared electronic medical records (EMRs), and patient navigators can help break down silos. Even small steps like consistent screening questions and proactive follow-up can make a difference.
the Therapeutic Shift & Possibility
Overlapping Therapies: New biologics and systemic therapies are effective for both skin and joint manifestations of psoriatic disease.
PsA Prevention: Emerging data suggests early systemic therapy for psoriasis may even prevent the progress of PsA.
Early Intervention: The convergence of therapies allows for thorough intervention, possibly starting treatment before a rheumatology consultation.
Overall Conclusion:
The article emphasizes that psoriasis and PsA are interconnected manifestations of a systemic inflammatory disease. Breaking down the barriers of siloed care and embracing a collaborative model is essential for optimizing patient outcomes and potentially preventing the progression of disease.